Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Classement en actions
#3628
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Prix de l'action
$3.71
Capitalisation boursière
$4.69B
Changement (1 jour)
2.44%
Changement (1 an)
-51.92%
Pays
CN
Échange Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Catégorie
Healthcare
Historique du rendement du dividende pour Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Le rendement du dividende (TTM) de Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (symbole boursier : 603392) au 2023-12-31 est : 0.96%
Rendement moyen du dividende sur les 5 dernières années : 0.32%
Rendement moyen du dividende sur les 5 dernières années : 0.32%
Historique du rendement du dividende de Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392) de 2013 à 2026
Rendement du dividende à la fin de chaque année (TTM)
| Année | Rendement du dividende | Changez |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2024 | 0.44% | -54.17% |
| 2023 | 0.96% | 772.73% |
| 2022 | 0.11% | 10.00% |
| 2021 | 0.10% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | 0.03% | -81.25% |
| 2018 | 0.16% | 33.33% |
| 2017 | 0.12% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | 2.78% | 4,533.33% |
| 2014 | 0.06% | -87.23% |
| 2013 | 0.47% | 0.00% |
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
| Entreprise | Rendement du dividende | Pays |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
